Table of Contents

United States Veterinary Pharmaceuticals Market Report 2017
1 Veterinary Pharmaceuticals Overview
    1.1 Product Overview and Scope of Veterinary Pharmaceuticals
    1.2 Classification of Veterinary Pharmaceuticals by Product Category
        1.2.1 United States Veterinary Pharmaceuticals Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States Veterinary Pharmaceuticals Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 Veterinary Biological Drugs
        1.2.4 Veterinary Preparations
        1.2.5 Others?
    1.3 United States Veterinary Pharmaceuticals Market by Application/End Users
        1.3.1 United States Veterinary Pharmaceuticals Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 Poultry
        1.3.3 Pets
        1.3.4 Other
    1.4 United States Veterinary Pharmaceuticals Market by Region
        1.4.1 United States Veterinary Pharmaceuticals Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West Veterinary Pharmaceuticals Status and Prospect (2012-2022)
        1.4.3 Southwest Veterinary Pharmaceuticals Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic Veterinary Pharmaceuticals Status and Prospect (2012-2022)
        1.4.5 New England Veterinary Pharmaceuticals Status and Prospect (2012-2022)
        1.4.6 The South Veterinary Pharmaceuticals Status and Prospect (2012-2022)
        1.4.7 The Midwest Veterinary Pharmaceuticals Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of Veterinary Pharmaceuticals (2012-2022)
        1.5.1 United States Veterinary Pharmaceuticals Sales and Growth Rate (2012-2022)
        1.5.2 United States Veterinary Pharmaceuticals Revenue and Growth Rate (2012-2022)

2 United States Veterinary Pharmaceuticals Market Competition by Players/Suppliers
    2.1 United States Veterinary Pharmaceuticals Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States Veterinary Pharmaceuticals Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States Veterinary Pharmaceuticals Average Price by Players/Suppliers (2012-2017)
    2.4 United States Veterinary Pharmaceuticals Market Competitive Situation and Trends
        2.4.1 United States Veterinary Pharmaceuticals Market Concentration Rate
        2.4.2 United States Veterinary Pharmaceuticals Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Veterinary Pharmaceuticals Manufacturing Base Distribution, Sales Area, Product Type

3 United States Veterinary Pharmaceuticals Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States Veterinary Pharmaceuticals Sales and Market Share by Region (2012-2017)
    3.2 United States Veterinary Pharmaceuticals Revenue and Market Share by Region (2012-2017)
    3.3 United States Veterinary Pharmaceuticals Price by Region (2012-2017)

4 United States Veterinary Pharmaceuticals Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States Veterinary Pharmaceuticals Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States Veterinary Pharmaceuticals Revenue and Market Share by Type (2012-2017)
    4.3 United States Veterinary Pharmaceuticals Price by Type (2012-2017)
    4.4 United States Veterinary Pharmaceuticals Sales Growth Rate by Type (2012-2017)

5 United States Veterinary Pharmaceuticals Sales (Volume) by Application (2012-2017)
    5.1 United States Veterinary Pharmaceuticals Sales and Market Share by Application (2012-2017)
    5.2 United States Veterinary Pharmaceuticals Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States Veterinary Pharmaceuticals Players/Suppliers Profiles and Sales Data
    6.1 Zoetis(Pfizer)
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Veterinary Pharmaceuticals Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Zoetis(Pfizer) Veterinary Pharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 MERIAL
        6.2.2 Veterinary Pharmaceuticals Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 MERIAL Veterinary Pharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Merial
        6.3.2 Veterinary Pharmaceuticals Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Merial Veterinary Pharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Lilly
        6.4.2 Veterinary Pharmaceuticals Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Lilly Veterinary Pharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Bayer
        6.5.2 Veterinary Pharmaceuticals Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Bayer Veterinary Pharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Boehringer
        6.6.2 Veterinary Pharmaceuticals Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Boehringer Veterinary Pharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Novartis
        6.7.2 Veterinary Pharmaceuticals Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Novartis Veterinary Pharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Virbac
        6.8.2 Veterinary Pharmaceuticals Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Virbac Veterinary Pharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Ceva
        6.9.2 Veterinary Pharmaceuticals Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Ceva Veterinary Pharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Vetoquinol
        6.10.2 Veterinary Pharmaceuticals Product Category, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Vetoquinol Veterinary Pharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 CAHIC
    6.12 Ringpu
    6.13 Dahuanong
    6.14 TECON
    6.15 BIOK
    6.16 Lukang Pharma
    6.17 JINYU Group
    6.18 China Animal Healthcare
    6.19 Jiangxi Yiling
    6.20 JIZHONG Pharmaceutical

7 Veterinary Pharmaceuticals Manufacturing Cost Analysis
    7.1 Veterinary Pharmaceuticals Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Veterinary Pharmaceuticals

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Veterinary Pharmaceuticals Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Veterinary Pharmaceuticals Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Veterinary Pharmaceuticals Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States Veterinary Pharmaceuticals Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States Veterinary Pharmaceuticals Sales Volume Forecast by Type (2017-2022)
    11.3 United States Veterinary Pharmaceuticals Sales Volume Forecast by Application (2017-2022)
    11.4 United States Veterinary Pharmaceuticals Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer